USAID has supported TB control and prevention in the Asia-Pacific region since 2006. USAID supports a region that includes nine out of the world’s 22 ‘high burden’ TB countries, many of them also facing alarming prevalence and incidence rates of multi-drug resistant TB (MDR-TB). In addition, co-infection of TB and HIV, in particular, and TB diagnosis and treatment among HIV infected patients remains a challenge.

USAID focuses on the development and implementation of innovative and scalable programs for TB control in the Asia-Pacific region, with a concentration on building comprehensive models to prevent and manage MDR-TB. USAID support strengthens national TB programs by providing assistance and introducing innovative and cost effective approaches to TB control.

Program Interventions

USAID’s TB program has included numerous successful activities including the following:

  • Engaged a wide range of health providers in TB control and strengthened capacities of Southeast Asian nations to develop locally based advocacy, communications, and social mobilization strategies.
  • Established the Thailand TB Active Surveillance Network, which has strengthened capacity for disease surveillance throughout the region.
  • Developed a new TB screening procedure which will be incorporated into regional and global World Health Organization guidelines to identify about 90 percent of HIV-infected patients with TB.
  • Strengthened collaboration between national TB and HIV programs by finalizing regional-specific TB and HIV training modules.
  • Introduced and disseminated the International Standards for Tuberculosis Care, strengthened TB laboratories through infrastructure and training across the region and provided assistance to national TB prevalence surveys in the China, Burma, and Thailand.
  • Supported operational research studies in infection control, HIV/TB, MDR-TB and diagnostics, and surveillance.
  • Supported the Technical Advisory Group meeting of WHO’s Western Pacific Regional Office, which addressed issues of MDR-TB, extensively drug-resistant TB, TB-HIV, and the strengthening of regional laboratory capacity.


TB program achievements across the Asia Pacific Regions at the end of 2012 included:

  • More than 367,000 new TB patients have been registered to receive Directly Observed Therapy- Short Course (the WHO-recommended tuberculosis control strategy) at the sites that received technical assistance with USAID support.
  • More than 66,240 individuals were reached through outreach activities for prevention and treatment information and services.
  • More than 6,700 new MDR-TB patients were diagnosed, with treatment initiated in USAID supported sites.
  • 366 local organizations received assistance to strengthen community-based approaches for managing MDR-TB. The “Promoting the Quality of Medicines” project is providing assistance for Southeast Asian countries to control and regulate counterfeit and substandard medicines.

Last updated: November 24, 2015

Share This Page